SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-002175
Filing Date
2015-03-13
Accepted
2015-03-13 16:50:57
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223389z10-k.htm 10-K 1343630
2 EX-10.39 a2223389zex-10_39.htm EX-10.39 33649
3 EX-21.1 a2223389zex-21_1.htm EX-21.1 2297
4 EX-23.1 a2223389zex-23_1.htm EX-23.1 2181
5 EX-31.1 a2223389zex-31_1.htm EX-31.1 6762
6 EX-31.2 a2223389zex-31_2.htm EX-31.2 6750
7 EX-32 a2223389zex-32.htm EX-32 8610
14 G895849.JPG g895849.jpg GRAPHIC 44761
  Complete submission text file 0001047469-15-002175.txt   11634902

Data Files

Seq Description Document Type Size
8 EX-101.INS tbph-20141231.xml EX-101.INS 2143036
9 EX-101.SCH tbph-20141231.xsd EX-101.SCH 61714
10 EX-101.CAL tbph-20141231_cal.xml EX-101.CAL 68891
11 EX-101.DEF tbph-20141231_def.xml EX-101.DEF 220593
12 EX-101.LAB tbph-20141231_lab.xml EX-101.LAB 597715
13 EX-101.PRE tbph-20141231_pre.xml EX-101.PRE 400152
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 15699972
SIC: 2834 Pharmaceutical Preparations